Sign inJoin waitlistJoin the waitlist

Marc Philippon

Fellowship | Director of Hip · Steadman Philippon Research Institute

Credentials: · ·

History

Fellowship | of Hip Fellowship · Steadman Philippon Research Institute
Present
Steadman Philippon Research Institute
Present
SPRI Sports Medicine Fellowship · Steadman Philippon Research Institute
Present

Orthopaedic Trauma
Orthopaedic Surgery
University of Miami/Jackson Health System
MCMASTER UNIV, HAMILTON

Research

The Warwick Agreement on femoroacetabular impingement syndrome (FAI syndrome): an international consensus statement
British Journal of Sports Medicine · 2016 · 809 citations
Outcomes following hip arthroscopy for femoroacetabular impingement with associated chondrolabral dysfunction: minimum two-year follow-up
Journal of Bone and Joint Surgery - British Volume · 2009 · First of 4 authors · 649 citations
The Development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool…
Arthroscopy · 2012 · 399 citations

Joseph Ruzbarsky
35 papers · 28 as a fellow
Robert LaPrade
34 papers
IB
Ioanna Bolia
30 papers · 20 as a resident
Jorge Chahla
26 papers · 17 as a resident
SC
Spencer Comfort
23 papers · 15 as a resident
Renato Locks
17 papers
RS
Rui Soares
15 papers · 14 as a resident
Marc Safran
14 papers
NF
Nicholas Felan
13 papers · 13 as a resident
Asheesh Bedi
12 papers
Bryan Kelly
12 papers · 4 as a resident
Hal Martin
11 papers

Grants

The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · UH3
PI · $2.6M · Steadman Philippon Research Institute
2020–2025
The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · UG3
PI · $522.3K · Steadman Philippon Research Institute
2020–2021

Clinical trials

Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis
Principal investigator · Unknown · Phase 1, Phase 2
Steadman Philippon Research Institute
2021–2025
Losartan to Improve Hip Microfracture
Principal investigator · Terminated · Phase 1, Phase 2
Steadman Philippon Research Institute
2020